Skip to content

John Hay

3 papers in the library · 68 citations · publishing 2020-2021

Papers

Sort Most recent Most cited

A qualitative and quantitative account of patient's experiences of ketamine and its antidepressant properties.

Journal of Psychopharmacology August 1, 2021 Rachael Sumner, Emme Chacko, Rebecca McMillan et al. 68 citations

Ketamine is central to one of the most rapidly growing areas of neuroscientific research into novel treatments for depression. Limited research has indicated that the psychedelic properties of ketamine may play a role in its antidepressant effects. The aim of the current study was to explore the psychedelic experiences and sustained impact of ketamine in major depressive disorder. In the...

Ketamine improves short-term plasticity in depression by enhancing sensitivity to prediction errors.

European Neuropsychopharmacology September 2020 Rachael Sumner, Rebecca McMillan, Meg J. Spriggs et al.

Major depressive disorder negatively impacts the sensitivity and adaptability of the brain's predictive coding framework. The current electroencephalography study into the antidepressant properties of ketamine investigated the downstream effects of ketamine on predictive coding and short-term plasticity in thirty patients with depression using the auditory roving mismatch negativity (rMMN). The...

Ketamine Enhances Visual Sensory Evoked Potential Long-term Potentiation in Patients With Major Depressive Disorder.

Biological Psychiatry: Cognitive Neuroscience and Neuroimaging January 2020 Rachael Sumner, Rebecca McMillan, Meg J. Spriggs et al.

The rapid-acting clinical effects of ketamine as a novel treatment for depression along with its complex pharmacology have made it a growing research area. One of the key mechanistic hypotheses for how ketamine works to alleviate depression is by enhancing long-term potentiation (LTP)-mediated neural plasticity. The objective of this study was to investigate the plasticity hypothesis in 30...